Panagiotis Marakos

Prof. Panagiotis Marakos


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
VPVassiliki Panteleon
Vassiliki Panteleon
Ioannis KostakisIoannis Kostakis
Ioannis Kostakis
PMPanagiotis Marakos
Panagiotis Marakos
NPNicole Pouli
Nicole Pouli
IAIoanna Andreadou
Ioanna Andreadou

1 October 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MMMaria Michailidou
Maria Michailidou
VGVasiliki K Giannouli
Vasiliki K Giannouli
VKVasilios Kotsikoris
Vasilios Kotsikoris
OPOlga Papadodima
Olga Papadodima
GKGeorgia Kontogianni
Georgia Kontogianni
HLHeleni Loutrari
Heleni Loutrari

1 June 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
APAthanasios Papastathopoulos
Athanasios Papastathopoulos
NLNikolaos Lougiakis
Nikolaos Lougiakis
Ioannis KostakisIoannis Kostakis
Ioannis Kostakis
PMPanagiotis Marakos
Panagiotis Marakos
NPNicole Pouli
Nicole Pouli
Dimitris KletsasDimitris Kletsas
Dimitris Kletsas

1 January 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
OAOrestis Argyros
Orestis Argyros
NLNikolaos Lougiakis
Nikolaos Lougiakis
EKEva Kouvari
Eva Kouvari
APAlexandra Papafotika
Alexandra Papafotika
Catherine RaptopoulouCatherine Raptopoulou
Catherine Raptopoulou
CTConstantin Tamvakopoulos
Constantin Tamvakopoulos

10 September 2013 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
SKShivaji S. Kadam
Shivaji S. Kadam
LMLukáš Maier
Lukáš Maier
Ioannis KostakisIoannis Kostakis
Ioannis Kostakis
NPNicole Pouli
Nicole Pouli
JTJaromír Toušek
Jaromír Toušek
RMRadek Marek
Radek Marek

27 February 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MGMaria Georgiou
Maria Georgiou
NLNikolaos Lougiakis
Nikolaos Lougiakis
Roxane TentaRoxane Tenta
Roxane Tenta
KGKaterina Gioti
Katerina Gioti
SBStavroula Baritaki
Stavroula Baritaki
DSDimitrios Stellas
Dimitrios Stellas
Purine analogues are important therapeutic tools due to their affinity to enzymes or receptors that are involved in critical biological processes. In this study, new 1,4,6-trisubstituted pyrazolo[3,4-b]pyridines were designed and synthesized, and their cytotoxic potential was been studied. The new derivatives were prepared through suitable arylhydrazines, and upon successive conversion first to aminopyrazoles, they were converted then to 1,6-disubstituted pyrazolo[3,4-b]pyridine-4-ones; this served as the starting point for the synthesis of the target compounds. The cytotoxic activity of the derivatives was evaluated against several human and murine cancer cell lines. Substantial structure activity relationships (SARs) could be extracted, mainly concerning the 4-alkylaminoethyl ethers, which showed potent in vitro antiproliferative activity in the low μM level (0.75–4.15 μΜ) without affecting the proliferation of normal cells. The most potent analogues underwent in vivo evaluation and were found to inhibit tumor growth in vivo in an orthotopic breast cancer mouse model. The novel compounds exhibited no systemic toxicity; they affected only the implanted tumors and did not interfere with the immune system of the animals. Our results revealed a very potent novel compound which could be an ideal lead for the discovery of promising anti-tumor agents, and could also be further explored for combination treatments with immunotherapeutic drugs.